No abstract available
MeSH terms
-
Angiotensin II Type 1 Receptor Blockers / adverse effects
-
Angiotensin II Type 1 Receptor Blockers / pharmacology
-
Angiotensin II Type 1 Receptor Blockers / therapeutic use*
-
Clinical Trials as Topic
-
Diabetes Mellitus, Type 2 / complications*
-
Diabetes Mellitus, Type 2 / epidemiology
-
Diabetes Mellitus, Type 2 / ethnology
-
Diabetic Nephropathies / drug therapy*
-
Diabetic Nephropathies / epidemiology
-
Diabetic Nephropathies / ethnology
-
Diabetic Nephropathies / prevention & control
-
Humans
-
Japan / epidemiology
-
Japan / ethnology
-
Kidney Diseases / drug therapy*
-
Kidney Diseases / epidemiology
-
Kidney Diseases / ethnology
-
Kidney Diseases / prevention & control
-
Kidney Failure, Chronic / epidemiology
-
Kidney Failure, Chronic / physiopathology
-
Kidney Failure, Chronic / prevention & control
-
Losartan / adverse effects
-
Losartan / pharmacology
-
Losartan / therapeutic use*
-
Renin-Angiotensin System / drug effects
-
Renin-Angiotensin System / physiology
Substances
-
Angiotensin II Type 1 Receptor Blockers
-
Losartan